Perma-Pipe International Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Perma-Pipe International Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jan 31, 2018 | $105.25M | Apr 19, 2018 |
| FY2017 | Jan 31, 2017 | $98.85M | Apr 19, 2018 |
| FY2016 | Jan 31, 2016 | $122.70M | Apr 14, 2017 |
| FY2015 | Jan 31, 2015 | $126.92M | Apr 28, 2016 |
| FY2014 | Jan 31, 2014 | $226.84M | Apr 16, 2015 |
| FY2013 | Jan 31, 2013 | $168.81M | Apr 15, 2014 |
| FY2012 | Jan 31, 2012 | $233.50M | May 2, 2013 |
| FY2011 | Jan 31, 2011 | $218.60M | May 9, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $69.49M | Apr 16, 2026 |
| FY2026 | Jan 31, 2025 | $53.25M | Apr 16, 2026 |
| FY2025 | Jan 31, 2024 | $41.46M | May 1, 2025 |
| FY2024 | Jan 31, 2023 | $38.30M | Apr 26, 2024 |
| FY2023 | Jan 31, 2022 | $32.53M | Apr 27, 2023 |
| FY2021 | Jan 31, 2021 | $11.18M | Apr 19, 2022 |
| FY2020 | Jan 31, 2020 | $29.05M | Apr 15, 2021 |
| FY2019 | Jan 31, 2019 | $23.32M | Apr 21, 2020 |
| FY2019 | Jan 31, 2018 | $11.74M | Apr 16, 2019 |
| FY2017 | Jan 31, 2017 | $11.72M | Apr 19, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $17.04M | Apr 16, 2026 |
| FY2026 | Jan 31, 2025 | $8.98M | Apr 16, 2026 |
| FY2025 | Jan 31, 2024 | $10.47M | May 1, 2025 |
| FY2024 | Jan 31, 2023 | $5.95M | Apr 26, 2024 |
| FY2023 | Jan 31, 2022 | $6.06M | Apr 27, 2023 |
| FY2021 | Jan 31, 2021 | ($7.64M) | Apr 19, 2022 |
| FY2020 | Jan 31, 2020 | $3.58M | Apr 15, 2021 |
| FY2019 | Jan 31, 2019 | ($550.0K) | Apr 21, 2020 |
| FY2019 | Jan 31, 2018 | ($9.98M) | Apr 16, 2019 |
| FY2017 | Jan 31, 2017 | ($12.47M) | Apr 19, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $29.45M | Apr 16, 2026 |
| FY2026 | Jan 31, 2025 | $20.30M | Apr 16, 2026 |
| FY2025 | Jan 31, 2024 | $13.36M | May 1, 2025 |
| FY2024 | Jan 31, 2023 | $11.14M | Apr 26, 2024 |
| FY2023 | Jan 31, 2022 | $8.11M | Apr 27, 2023 |
| FY2021 | Jan 31, 2021 | ($11.38M) | Apr 19, 2022 |
| FY2020 | Jan 31, 2020 | $4.88M | Apr 15, 2021 |
| FY2019 | Jan 31, 2019 | $2.72M | Apr 21, 2020 |
| FY2019 | Jan 31, 2018 | ($9.51M) | Apr 16, 2019 |
| FY2017 | Jan 31, 2017 | ($11.58M) | Apr 19, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | $100.0K | May 1, 2025 |
| FY2025 | Jan 31, 2024 | $500.0K | May 1, 2025 |
| FY2024 | Jan 31, 2023 | $600.0K | Apr 26, 2024 |
| FY2023 | Jan 31, 2022 | $400.0K | Apr 27, 2023 |
| FY2021 | Jan 31, 2021 | $300.0K | Apr 19, 2022 |
| FY2020 | Jan 31, 2020 | $300.0K | Apr 15, 2021 |
| FY2019 | Jan 31, 2019 | $200.0K | Apr 21, 2020 |
| FY2019 | Jan 31, 2018 | $300.0K | Apr 16, 2019 |
| FY2017 | Jan 31, 2017 | $200.0K | Apr 19, 2018 |
| FY2016 | Jan 31, 2016 | $1.10M | Apr 14, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $9.17M | Apr 16, 2026 |
| FY2026 | Jan 31, 2025 | $13.93M | Apr 16, 2026 |
| FY2025 | Jan 31, 2024 | $14.73M | May 1, 2025 |
| FY2024 | Jan 31, 2023 | ($1.24M) | Apr 26, 2024 |
| FY2023 | Jan 31, 2022 | ($2.57M) | Apr 27, 2023 |
| FY2021 | Jan 31, 2021 | $165.0K | Apr 19, 2022 |
| FY2020 | Jan 31, 2020 | $4.09M | Apr 15, 2021 |
| FY2019 | Jan 31, 2019 | $4.98M | Apr 21, 2020 |
| FY2019 | Jan 31, 2018 | ($1.84M) | Apr 16, 2019 |
| FY2017 | Jan 31, 2017 | ($5.46M) | Apr 19, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $10.44M | Apr 16, 2026 |
| FY2026 | Jan 31, 2025 | $2.88M | Apr 16, 2026 |
| FY2025 | Jan 31, 2024 | $11.11M | May 1, 2025 |
| FY2024 | Jan 31, 2023 | $6.98M | Apr 26, 2024 |
| FY2023 | Jan 31, 2022 | $2.26M | Apr 27, 2023 |
| FY2021 | Jan 31, 2021 | $1.96M | Apr 19, 2022 |
| FY2020 | Jan 31, 2020 | $1.90M | Apr 15, 2021 |
| FY2019 | Jan 31, 2019 | $1.36M | Apr 21, 2020 |
| FY2019 | Jan 31, 2018 | $2.53M | Apr 16, 2019 |
| FY2017 | Jan 31, 2017 | $2.26M | Apr 19, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $217.49M | Apr 16, 2026 |
| FY2026 | Jan 31, 2025 | $165.24M | Apr 16, 2026 |
| FY2025 | Jan 31, 2024 | $155.71M | May 1, 2025 |
| FY2024 | Jan 31, 2023 | $122.97M | Apr 26, 2024 |
| FY2023 | Jan 31, 2022 | $123.40M | Apr 27, 2023 |
| FY2021 | Jan 31, 2021 | $102.69M | Apr 19, 2022 |
| FY2020 | Jan 31, 2020 | $112.23M | Apr 15, 2021 |
| FY2019 | Jan 31, 2019 | $102.21M | Apr 21, 2020 |
| FY2019 | Jan 31, 2018 | $104.58M | Apr 16, 2019 |
| FY2017 | Jan 31, 2017 | $101.61M | Apr 19, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $90.64M | Apr 16, 2026 |
| FY2026 | Jan 31, 2025 | $72.14M | Apr 16, 2026 |
| FY2026 | Jan 31, 2024 | $65.71M | Apr 16, 2026 |
| FY2025 | Jan 31, 2023 | $57.78M | May 1, 2025 |
| FY2024 | Jan 31, 2022 | $54.46M | Apr 26, 2024 |
| FY2023 | Jan 31, 2021 | $49.31M | Apr 27, 2023 |
| FY2021 | Jan 31, 2020 | $55.63M | Apr 19, 2022 |
| FY2020 | Jan 31, 2019 | $51.70M | Apr 15, 2021 |
| FY2019 | Jan 31, 2018 | $51.17M | Apr 21, 2020 |
| FY2019 | Jan 31, 2017 | $59.41M | Apr 16, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $2.19M | Apr 16, 2026 |
| FY2026 | Jan 31, 2025 | $2.06M | Apr 16, 2026 |
| FY2026 | Jan 31, 2024 | $2.22M | Apr 16, 2026 |
| FY2025 | Jan 31, 2023 | $2.23M | May 1, 2025 |
| FY2023 | Dec 31, 2022 | $2.23M | Apr 27, 2023 |
| FY2024 | Jan 31, 2022 | $2.34M | Apr 26, 2024 |
| FY2023 | Dec 31, 2021 | $2.34M | Apr 27, 2023 |
| FY2021 | Jan 31, 2021 | $2.33M | Apr 19, 2022 |
| FY2023 | Dec 31, 2020 | $2.33M | Apr 27, 2023 |
| FY2020 | Jan 31, 2020 | $2.25M | Apr 15, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $37.14M | Apr 16, 2026 |
| FY2026 | Jan 31, 2025 | $20.10M | Apr 16, 2026 |
| FY2025 | Jan 31, 2024 | $12.09M | May 1, 2025 |
| FY2024 | Jan 31, 2023 | $1.62M | Apr 26, 2024 |
| FY2023 | Jan 31, 2022 | ($2.30M) | Apr 27, 2023 |
| FY2021 | Jan 31, 2021 | ($8.36M) | Apr 19, 2022 |
| FY2020 | Jan 31, 2020 | ($715.0K) | Apr 15, 2021 |
| FY2019 | Jan 31, 2019 | ($4.29M) | Apr 21, 2020 |
| FY2019 | Jan 31, 2018 | ($3.74M) | Apr 21, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $18.72M | Apr 16, 2026 |
| FY2026 | Jan 31, 2025 | $15.72M | Apr 16, 2026 |
| FY2025 | Jan 31, 2024 | $5.85M | May 1, 2025 |
| FY2024 | Jan 31, 2023 | $5.77M | Apr 26, 2024 |
| FY2023 | Jan 31, 2022 | $8.21M | Apr 27, 2023 |
| FY2021 | Jan 31, 2021 | $7.17M | Apr 19, 2022 |
| FY2020 | Jan 31, 2020 | $13.37M | Apr 15, 2021 |
| FY2019 | Jan 31, 2019 | $10.16M | Apr 21, 2020 |
| FY2019 | Jan 31, 2018 | $7.08M | Apr 16, 2019 |
| FY2017 | Jan 31, 2017 | $7.60M | Apr 19, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | $15.21M | May 1, 2025 |
| FY2026 | Jan 21, 2025 | $12.70M | Apr 16, 2026 |
| FY2024 | Mar 31, 2024 | $16.02M | Apr 26, 2024 |
| FY2026 | Jan 31, 2024 | $15.21M | Apr 16, 2026 |
| FY2024 | Jan 31, 2023 | $13.60M | Apr 26, 2024 |
| FY2023 | Jan 31, 2022 | $14.39M | Apr 27, 2023 |
| FY2021 | Jan 31, 2021 | $6.27M | Apr 19, 2022 |
| FY2020 | Jan 31, 2020 | $6.72M | Apr 15, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 2 | Apr 16, 2026 |
| FY2026 | Jan 31, 2025 | 1 | Apr 16, 2026 |
| FY2025 | Jan 31, 2024 | 1 | May 1, 2025 |
| FY2024 | Jan 31, 2023 | 0 | Apr 26, 2024 |
| FY2023 | Jan 31, 2022 | 0 | Apr 27, 2023 |
| FY2021 | Jan 31, 2021 | 0 | Apr 19, 2022 |
| FY2020 | Jan 31, 2020 | 0 | Apr 15, 2021 |
| FY2019 | Jan 31, 2019 | 0 | Apr 21, 2020 |
| FY2014 | Jan 31, 2015 | 0 | Apr 16, 2015 |
| FY2014 | Jan 31, 2014 | 2 | Apr 16, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 2 | Apr 16, 2026 |
| FY2026 | Jan 31, 2025 | 1 | Apr 16, 2026 |
| FY2025 | Jan 31, 2024 | 1 | May 1, 2025 |
| FY2024 | Jan 31, 2023 | 0 | Apr 26, 2024 |
| FY2023 | Jan 31, 2022 | 0 | Apr 27, 2023 |
| FY2021 | Jan 31, 2021 | 0 | Apr 19, 2022 |
| FY2020 | Jan 31, 2020 | 0 | Apr 15, 2021 |
| FY2019 | Jan 31, 2019 | 0 | Apr 21, 2020 |
| FY2014 | Jan 31, 2015 | 0 | Apr 16, 2015 |
| FY2014 | Jan 31, 2014 | 2 | Apr 16, 2015 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 8.12M | Apr 16, 2026 |
| FY2026 | Jan 31, 2025 | 7.98M | Apr 16, 2026 |
| FY2025 | Jan 31, 2024 | 8.02M | May 1, 2025 |
| FY2023 | Jan 31, 2023 | 8.00M | Apr 27, 2023 |
| FY2023 | Jan 31, 2022 | 8.15M | Apr 27, 2023 |
| FY2021 | Jan 31, 2021 | 8.17M | Apr 19, 2022 |
| FY2020 | Jan 31, 2020 | 8.05M | Apr 15, 2021 |
| FY2019 | Jan 31, 2019 | 7.85M | Apr 21, 2020 |
| FY2019 | Jan 31, 2018 | 7.72M | Apr 16, 2019 |
| FY2017 | Jan 31, 2017 | 7.60M | Apr 19, 2018 |